SE7607331L - Pyrrolidoner och forfarande for deras framstellning - Google Patents

Pyrrolidoner och forfarande for deras framstellning

Info

Publication number
SE7607331L
SE7607331L SE7607331A SE7607331A SE7607331L SE 7607331 L SE7607331 L SE 7607331L SE 7607331 A SE7607331 A SE 7607331A SE 7607331 A SE7607331 A SE 7607331A SE 7607331 L SE7607331 L SE 7607331L
Authority
SE
Sweden
Prior art keywords
pyrrolidones
procedures
preparation
Prior art date
Application number
SE7607331A
Other languages
English (en)
Inventor
W Bartmann
R Kunstmann
U Lerch
B Scholkens
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of SE7607331L publication Critical patent/SE7607331L/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
SE7607331A 1975-06-27 1976-06-24 Pyrrolidoner och forfarande for deras framstellning SE7607331L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752528664 DE2528664A1 (de) 1975-06-27 1975-06-27 Pyrrolidone und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
SE7607331L true SE7607331L (sv) 1976-12-28

Family

ID=5950059

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7607331A SE7607331L (sv) 1975-06-27 1976-06-24 Pyrrolidoner och forfarande for deras framstellning

Country Status (14)

Country Link
JP (1) JPS525764A (sv)
AT (1) AT365575B (sv)
BE (1) BE843505A (sv)
CH (1) CH623809A5 (sv)
DE (1) DE2528664A1 (sv)
DK (1) DK287476A (sv)
ES (1) ES449095A1 (sv)
FR (1) FR2316943A1 (sv)
GB (1) GB1553595A (sv)
IL (1) IL49916A0 (sv)
LU (1) LU75235A1 (sv)
NL (1) NL7606773A (sv)
SE (1) SE7607331L (sv)
ZA (1) ZA763802B (sv)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE423813B (sv) * 1976-08-06 1982-06-07 Pfizer Forfarande for framstellning av 1,5-disubstituerade pyrrolidoner med terapeutiska egenskaper
US4772601A (en) * 1988-01-25 1988-09-20 Hoechst-Roussel Pharmaceuticals, Inc. 5-Substituted 1-(4-(1-pyrrolidinyl)-2-butynyl)-2-pyrrolidinones, pharmaceutical compositions and use
WO2001046140A1 (en) 1999-12-22 2001-06-28 Pfizer Products Inc. Ep4 receptor selective agonists in the treatment of osteoporosis
WO2002024647A1 (fr) * 2000-09-21 2002-03-28 Ono Pharmaceutical Co., Ltd. Agonistes du recepteur de l'ep4 comprenant comme principe actif des derives de la 8-azaprostaglandine
SK5562003A3 (en) 2000-11-27 2004-08-03 Pfizer Prod Inc EP4 receptor selective agonists in the treatment of osteoporosis
DK1408961T3 (da) 2001-07-16 2007-11-05 Hoffmann La Roche 2 pyrrolidon-derivater som prostanoide agonister
KR20040015364A (ko) 2001-07-16 2004-02-18 에프. 호프만-라 로슈 아게 Ep4 수용체 작용물질로서의 프로스타글란딘 유사체
IL159996A0 (en) 2001-07-23 2004-06-20 Ono Pharmaceutical Co Remedies for diseases with bone mass loss having ep4 agonist as the active ingredient
BR0308738A (sv) * 2002-03-18 2005-01-11
US6573294B1 (en) * 2002-05-14 2003-06-03 Allergan, Inc. 8-azaprostaglandin analogs as agents for lowering intraocular pressure
CN1735597A (zh) 2003-01-10 2006-02-15 霍夫曼-拉罗奇有限公司 作为前列腺素激动剂的2-哌啶酮衍生物
US7179820B2 (en) 2003-06-06 2007-02-20 Allergan, Inc. Piperidinyl prostaglandin E analogs
WO2014015247A1 (en) 2012-07-19 2014-01-23 Cayman Chemical Company, Inc. Difluorolactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated disease and conditions
EP3235817B1 (en) 2013-03-15 2018-12-12 Cayman Chemical Company, Incorporated Lactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated diseases and conditions
AU2014229065B2 (en) 2013-03-15 2017-03-09 Cayman Chemical Company, Inc. Methods of synthesizing a difluorolactam analog
US9676712B2 (en) 2013-03-15 2017-06-13 Cayman Chemical Company, Inc. Lactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions
AU2014290512A1 (en) 2013-07-19 2015-11-12 Cayman Chemical Company, Inc. Methods, systems, and compositions for promoting bone growth

Also Published As

Publication number Publication date
ES449095A1 (es) 1977-12-16
NL7606773A (nl) 1976-12-29
FR2316943A1 (fr) 1977-02-04
JPS525764A (en) 1977-01-17
FR2316943B1 (sv) 1978-11-03
LU75235A1 (sv) 1977-03-16
DK287476A (da) 1976-12-28
ZA763802B (en) 1977-05-25
IL49916A0 (en) 1976-08-31
CH623809A5 (en) 1981-06-30
AT365575B (de) 1982-01-25
DE2528664A1 (de) 1977-01-13
BE843505A (fr) 1976-12-28
GB1553595A (en) 1979-09-26
ATA467976A (de) 1981-06-15

Similar Documents

Publication Publication Date Title
SE7803660L (sv) Cefemderivat och forfarande for deras framstellning
SE7804185L (sv) Cefemderivat och forfarande for deras framstellning
SE7614218L (sv) Basiskt substituerade indolderivat och forfarande for deras framstellning
SE7802853L (sv) Cefemderivat och forfarande for deras framstellning
SE7607331L (sv) Pyrrolidoner och forfarande for deras framstellning
SE429236B (sv) Alkoxisilanolklusterforeningar och forfarande for deras framstellning
SE7810312L (sv) Fenylisotiocyanatderivat och framstellning derav
SE7610630L (sv) Hypolipemiska foreningar och forfarande for deras framstellning
SE7512354L (sv) Pyrrolidoner och forfarande for deras framstellning
SE7709333L (sv) Dihydro-oxo-nikotinsyror och forfarande for deras framstellning
SE7605500L (sv) Antrakinon-bis-amidiner och forfarande for deras framstellning
SE7705873L (sv) Bensensulfonykarbamider och forfarande for deras framstellning
SE426166B (sv) Fortjockad och tverbunden vattenhaltig skumsprengemneskomposition
SE7613947L (sv) Sekunder eteraminer och forfarande for deras framstellning
SE7605069L (sv) 14beta-hydroxy 3-deoxikardenolider och forfarande for deras framstellning
SE7607330L (sv) Pyrrolidoner och forfarande for deras framstellning
SE7514113L (sv) 1-alkyl-2-(fenoximetyl)-5-nitroimidazoler och forfarande for deras framstellning
SE7613948L (sv) Nya pyrrolidoner och forfarande for deras framstellning
SE432424B (sv) Halogenerade alkoxisilanforeningar och forfarande for deras framstellning
SE7607241L (sv) Aralifatiska dihalogenforeningar och forfarande for framstellning derav
SE7606071L (sv) Aromkomposition och forfarande for framstellning derav
SE7614386L (sv) Bensamider och forfarande for framstellning derav
SE7600704L (sv) Difenyleter-derivat och forfarande for framstellning derav
SE7805874L (sv) 1-fenyl-1-metoxi-2-amino-etanderivat och forfarande for framstellning derav
SE7607956L (sv) 1-metyl-2-(fenyloximetyl)-5-nitroimidazoler och forfarande for deras framstellning